Diaceutics sees revenue rising about 13% in H1
Diagnostic commercialisation Diaceutics said it expected to report a rise in first-half revenue amid ongoing momentum following the launch of its diagnostic commercialisation platform in...
Thu, 08/07/2021 - 09:42